Science Explorer Back to mapMap

Most cited papers from Albert Schweitzer Ziekenhuis

What are the most cited papers from Albert Schweitzer Ziekenhuis?

The most cited paper from Albert Schweitzer Ziekenhuis is "Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study" (Philippe Moreau et al., 2019), with 973 citations. Next come "Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial" (911) and "Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19" (732).

Showing 50 of 60 papers. Every paper with more than 158 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study Philippe Moreau et al. · The Lancet Open access 3 Jun 2019 973
2 Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial Caroline A. H. Klazen et al. · The Lancet Open access 10 Aug 2010 911
3 Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group et al. · JAMA Open access353 authors 6 Jul 2021 732
4 A prospective validation of the HEART score for chest pain patients at the emergency department Barbra E. Backus, A. Jacob Six, Johannes C. Kelder et al. · International Journal of Cardiology Open access 7 Mar 2013 590
5 Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study Meelan Bul, Xiaoye Zhu, R. Valdagni et al. · European Urology 12 Nov 2012 545
6 Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia J. Willem L. Tideman, Margaretha C. C. Snabel, Milly S. Tedja et al. · JAMA Ophthalmology Open access 20 Oct 2016 441
7 Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study Michèle Cavo et al. · The Lancet Haematology Open access 30 Apr 2020 387
8 Exhaled Breath Profiling Enables Discrimination of Chronic Obstructive Pulmonary Disease and Asthma Niki Fens, Aeilko Having Zwinderman, Marc P. van der Schee et al. · American Journal of Respiratory and Critical Care Medicine 27 Aug 2009 365
9 The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial Willeke F. Westendorp et al. · The Lancet Open access 19 Jan 2015 339
10 Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT-proven uncomplicated acute diverticulitis Lidewine Daniels et al. · British journal of surgery Open access 30 Sep 2016 329
11 Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET – Randomised controlled trial Nicky H. G. M. Peters, Stijn van Esser, Maurice A. A. J. van den Bosch et al. · European Journal of Cancer 31 Dec 2010 325
12 Bisoprolol and Fluvastatin for the Reduction of Perioperative Cardiac Mortality and Myocardial Infarction in Intermediate-Risk Patients Undergoing Noncardiovascular Surgery Martin Dunkelgrün, Eric H. Boersma, Olaf Schouten et al. · Annals of Surgery Jun 2009 307
13 Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial Nadia Alam et al. · The Lancet Respiratory Medicine 29 Nov 2017 293
14 Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT–FFR trial Elvin Kedhi et al. · European Heart Journal Open access 25 Jun 2021 288
15 Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns) Martin Stocker et al. · The Lancet 13 Jul 2017 279
16 A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma Henk M. Lokhorst et al. · Blood Open access 30 Oct 2009 279
17 COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus Lydia Scarfò et al. · Leukemia Open access 9 Jul 2020 276
18 Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR Andrew G Spencer et al. · Haematologica Open access 20 Sep 2018 262
19 Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial Susanne G. H. Olthuis et al. · The Lancet Open access 29 Mar 2023 258
20 Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study Mariëlle Kocken, Theo J.M. Helmerhorst, Johannes Hans Berkhof et al. · The Lancet Oncology 30 Apr 2011 254
21 Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients Wouter A. A. de Steenhuijsen Piters, Elisabeth G. W. Huijskens, Anne L. Wyllie et al. · The ISME Journal Open access 7 Jul 2015 253
22 Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial Clemens von Birgelen, Marlies M. Kok, Liefke C. van der Heijden et al. · The Lancet Open access 30 Oct 2016 251
23 Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial Jasper Jan Brugts et al. · The Lancet Open access 20 May 2023 248
24 European Guideline on IgG4‐related digestive disease – UEG and SGF evidence‐based recommendations Matthias J. Löhr et al. · United European Gastroenterology Journal Open access 18 Jun 2020 248
25 A comparison of hemiarthroplasty with total hip replacement for displaced intracapsular fracture of the femoral neck Michel P.J. van den Bekerom, E. F. Hilverdink, Inger Nicoline Sierevelt et al. · Journal of Bone and Joint Surgery - British Volume Open access 30 Sep 2010 248
26 Idiopathic Retroperitoneal Fibrosis Eric F.H. van Bommel, Inger Jansen, Tadek R. Hendriksz et al. · Medicine Jul 2009 243
27 Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities Arnon Philip Kater et al. · NEJM Evidence 13 May 2022 240
28 Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial Cristina E. Firanescu, Jolanda De Vries, Paul Lodder et al. · BMJ Open access 9 May 2018 239
29 The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature Hánah N. Rier, Agnes Jager, Stefan Sleijfer et al. · The Oncologist Open access 13 Jul 2016 228
30 Ecological Effects of Selective Decontamination on Resistant Gram-negative Bacterial Colonization Evelien A. N. Oostdijk, Anne Marie G. A. de Smet, Hetty E. M. Blok et al. · American Journal of Respiratory and Critical Care Medicine 3 Dec 2009 226
31 Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration Marcel J.M. Kofflard, Folkert J. ten Cate, Chris van der Lee et al. · Journal of the American College of Cardiology Open access Mar 2003 220
32 Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial Daniël P. V. Lambrichts et al. · ˜The œLancet. Gastroenterology & hepatology Open access178 authors 7 Jun 2019 216
33 A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer Eva R. Groenewoud et al. · Human Reproduction Open access 13 May 2016 216
34 Concentrations of Blood Components in Commercial Platelet-Rich Plasma Separation Systems: A Review of the Literature Bart W. Oudelaar, Joost C. Peerbooms, Rianne Huis in ‘t Veld et al. · The American Journal of Sports Medicine Open access 16 Jan 2018 212
35 Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients Harry Dolstra et al. · Clinical Cancer Research 9 Mar 2017 212
36 Comparison of eight prehospital stroke scales to detect intracranial large-vessel occlusion in suspected stroke (PRESTO): a prospective observational study Martijne H.C. Duvekot et al. · The Lancet Neurology Open access 9 Jan 2021 210
37 Induction of Labor versus Expectant Management in Women with Preterm Prelabor Rupture of Membranes between 34 and 37 Weeks: A Randomized Controlled Trial David P. van der Ham et al. · PLoS Medicine Open access 24 Apr 2012 207
38 Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) Erik J. Blok, Judith R. Kroep, Elma Meershoek‐Klein Kranenbarg et al. · JNCI Journal of the National Cancer Institute Open access 30 May 2017 203
39 Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: A randomized clinical trial Cornelis J.A. Hogewoning, Maaike C.G. Bleeker, Adriaan J. C. van den Brule et al. · International Journal of Cancer Open access 12 Sep 2003 203
40 Fosfomycin: Pharmacological, Clinical and Future Perspectives Anneke C. Dijkmans, Natalia V. Ortiz Zacarı́as, Jacobus Burggraaf et al. · Antibiotics Open access 31 Oct 2017 200
41 Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial David P. van der Ham, Jantien L. van der Heyden, Brent C. Opmeer et al. · American Journal of Obstetrics and Gynecology Open access 20 Jul 2012 200
42 Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial Ruth Kaufmann, Jens Anthony Halm, Hasan Huseyin Eker et al. · The Lancet 17 Feb 2018 195
43 Digital morphology analyzers in hematology: ICSH review and recommendations Alexander F. Kratz, Szu‐Hee Lee, Gina Zini et al. · International Journal of Laboratory Hematology Open access 2 May 2019 192
44 Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy Jaco A. C. van Bruggen, Anne W. J. Martens, Joseph A. Fraietta et al. · Blood Open access 10 May 2019 192
45 Ten‐year recurrence rates for breast cancer subtypes in the Netherlands: A large population‐based study Marissa Corine van Maaren, Linda de Munck, Luc J. A. Strobbe et al. · International Journal of Cancer Open access 28 Oct 2018 189
46 Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study Anne Marie G. A. de Smet, Jan A. J. W. Kluytmans, Hetty E. M. Blok et al. · The Lancet Infectious Diseases 30 Apr 2011 187
47 Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial Philippe Moreau et al. · The Lancet Oncology Open access 13 Sep 2021 180
48 Morbidly Obese Human Subjects Have Increased Peripheral Blood CD4+ T Cells With Skewing Toward a Treg- and Th2-Dominated Phenotype Kim van der Weerd, Willem A. Dik, Benjamin Schrijver et al. · Diabetes Open access 7 Jan 2012 179
49 Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia W. W. Vrijland, M. Petrousjka van den Tol, Roland W. Luijendijk et al. · British journal of surgery Mar 2002 177
50 Stimulation of osteogenic differentiation in human osteoprogenitor cells by pulsed electromagnetic fields: an in vitro study Justus H.W. Jansen, Olav P. van der Jagt, Bas J. Punt et al. · BMC Musculoskeletal Disorders Open access 23 Aug 2010 176

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.